Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes
Marta Belmonte,Alberto Foà,Pasquale Paolisso,Luca Bergamaschi,Emanuele Gallinoro,Alberto Polimeni,Roberto Scarsini,Saverio Muscoli,Sara Amicone,Antonio De Vita,Angelo Villano,Francesco Angeli,Matteo Armillotta,Vincenzo Sucato,Saverio Tremamunno,Doralisa Morrone,Ciro Indolfi,Pasquale Perrone Filardi,Flavio Ribichini,Gaetano Antonio Lanza,Alaide Chieffo,Emanuele Barbato,Carmine Pizzi
DOI: https://doi.org/10.1016/j.pcad.2024.10.006
IF: 11.278
2024-10-24
Progress in Cardiovascular Diseases
Abstract:The prevalence of coronary microvascular dysfunction (CMD) beyond the spectrum of chronic coronary syndromes (CCS) is non-negligible, pertaining to pathophysiological and therapeutical implications. Thanks to the availability of accurate and safe non-invasive technique, CMD can be identified as a key player in heart failure, cardiomyopathies, Takotsubo syndrome, aortic stenosis. While CMD is widely recognized as a cause of myocardial ischemia leading to a worse prognosis even in the absence of obstructive coronary artery disease, the characterization of CMD patterns beyond CCS might provide valuable insights on the underlying disease progression, being potentially a "red flag" of adverse cardiac remodeling and a major determinant of response to therapy and outcomes. In this review, we aimed to provide an overview of the latest evidence on the prevalence, mechanistic and prognostic implications of CMD beyond the spectrum of CCS (i.e. heart failure, cardiomyopathies, Takotsubo syndrome, aortic stenosis).
cardiac & cardiovascular systems